EGRP-Supported Epidemiology Consortia

Identification of Men with a Genetic Predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT) - Consortium Web Site
Since 2005	NIH Contacts:
	EGRP/NCI: Scientific Consortia Coordinator & IMPACT Liaison: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov Consortia Fellow: Brett Kaminski, M.P.H. brett.kaminski@nih.gov	Lead Investigator: Rosalind Eeles, Ph.D. The Institute of Cancer Research, UK Rosalind.Eeles@icr.ac.uk

Identification of Men with a Genetic Predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT) - Consortium Web Site

Since 2005

NIH Contacts:

EGRP/NCI:

Scientific Consortia Coordinator &
IMPACT Liaison:
Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Brett Kaminski, M.P.H.
brett.kaminski@nih.gov

Lead Investigator:

Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UK
Rosalind.Eeles@icr.ac.uk

View active grants and publications related to the Identification of Men with a Genetic Predisposition to Prostate Cancer (IMPACT) study

Key to Acronyms Used in Tables
EGRP	Epidemiology and Genomics Research Program
CDC	Centers for Disease Control and Prevention
DCB	Division of Cancer Biology
DCEG	Division of Cancer Epidemiology and Genetics
NCI	National Cancer Institute
NHGRI	National Human Genome Research Institute
NIEHS	National Institute of Environmental Health Sciences
NIH	National Institutes of Health
OCS	Office of Cancer Survivorship
OD	Office of the Director